All News #Library
Rare Diseases
Ocugen Gets Rare Disease Designation For OCU410ST Gene Therapy
27 May 2025 //
GLOBENEWSWIRE
Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit
11 Dec 2024 //
GLOBENEWSWIRE
Ocugen Receives Orphan Drug Designation From EMA For OCU410ST
20 Nov 2024 //
GLOBENEWSWIRE
US FDA grants orphan drug designation to Ocugen’s OCU410ST
29 Apr 2023 //
PHARMABIZ
Ocugen Announces OCU410ST Receives Orphan Drug Designation for Treatment of ABCA
27 Apr 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support